Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Future of Biologics in Part D

Published byKristin Estella McGee Modified over 6 years ago

Similar presentations

Presentation on theme: "The Future of Biologics in Part D"— Presentation transcript:

1 The Future of Biologics in Part D
Eric Toppy Director of Marketing Strategy Payer, Policy and Emerging Markets Centocor Ortho Biotech Services, LLC

2 Disclaimer The following content and opinions do not necessarily reflect the views and Opinions of Centocor Ortho Biotech Services, LLC

3 Medicare                                                                                                                                        Source: political cartoonist.com

4 Part D- A Success Story Part D Sources: WSJ-July 5, 2005
The Hill. com -Jan 11, 2007

5 Success Defined

6 Success Defined

7 Choice..Choice…Choice

8 Where are they? Source: Kaiser Family Foundation

9 The Gap Source: Kaiser Family Foundation

10 “D” & Impact on Biologics
Sub-Q Growth Accelerated Commoditization Multiple Customer Benefits Consumers Physicians Payers Membership growth Rebate Revenue

11 The “Benefit”

12

13 Donut Hole The “Donut Hole” in Part D is…..
Local establishment where MA-PD enrollment occurs A New diet craze sweeping the nation Patient who pays TROOP of $4,000 Place that most beneficiaries don’t visit due to pressures of competitive marketplace-gap coverage

14 Commercial Part D Programs
Cafeteria Plan Open & Closed Formularies Two Markets Drug Benefit Naïve Part D switch Adverse Selection

15 Biologics & Health Plans
Consumer Choice CMS recommendations Minimal benefit offering P&T Product Review Timing Part B vs. Part D Physician vs. self administered Medical Education Reimbursement CAP Program

16 CMS 2009 Health Plans to post drug formularies
BIO Position- All information that includes step edits, prior authorizations, quantity limits Continuation of Specialty Tiers BIO position- Impact on Patient Affordability Home Health Care Reimbursement 2009

17 Possible Threats to Biologics in Part D
Back to the Future Reduction in Part D payments Elections Reference Pricing BioSimilars Comparative Effectiveness-AHRQ Employer Shift = Increased MLR

18 The Future of Biologics and Part D
Biomarker/Genomics Competing Gov’t needs Reward for Innovation? EMRs Pay for Performance Report Cards Small Molecule Biologics

19 Thank You and Questions

Download ppt "The Future of Biologics in Part D"

Similar presentations

1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute Families USA Health Action 2005.

1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute Families USA Health Action 2005.
Achieving Affordable and Effective Health Care Reform Karen Ignagni President & CEO April 27, 2009.

Achieving Affordable and Effective Health Care Reform Karen Ignagni President & CEO April 27, 2009.
THE COMMONWEALTH FUND Figure 1. More Than Two-Thirds of Opinion Leaders Say Current Payment System Is Not Effective at Encouraging High Quality of Care.

THE COMMONWEALTH FUND Figure 1. More Than Two-Thirds of Opinion Leaders Say Current Payment System Is Not Effective at Encouraging High Quality of Care.
Braving the New World of P4P ! Tiffany Berry, MD Medical Director of Quality & Patient Safety Scott & White Healthcare Assistant Professor Family Medicine.

Braving the New World of P4P ! Tiffany Berry, MD Medical Director of Quality & Patient Safety Scott & White Healthcare Assistant Professor Family Medicine.
Update on Process Recommendations to the Executive Committee, Governor, and Exchange Board Next two sessions: options for analysis Goals/criteria Options.

Update on Process Recommendations to the Executive Committee, Governor, and Exchange Board Next two sessions: options for analysis Goals/criteria Options.
Value & Coverage Issue Brief Slides A Closer Look at Health Plan Coverage Policies and Approaches.

Value & Coverage Issue Brief Slides A Closer Look at Health Plan Coverage Policies and Approaches.
The Implications of the New Medicare Prescription Drug Legislation for Health Care Providers Anthony A. Barrueta Senior Counsel, Government Relations Kaiser.

The Implications of the New Medicare Prescription Drug Legislation for Health Care Providers Anthony A. Barrueta Senior Counsel, Government Relations Kaiser.
Government Influences on Cigna Business Acumen Course August 27 th, 2014.

Government Influences on Cigna Business Acumen Course August 27 th, 2014.
Spencer Berthelsen, M.D. Chairman and Managing Director Kelsey-Seybold Medical Group, PLLC.

Spencer Berthelsen, M.D. Chairman and Managing Director Kelsey-Seybold Medical Group, PLLC.
The Patient Protection & Affordable Care Act (ACA) implements broad, historic changes to U.S. health care Expanded access to health insurance and care.

The Patient Protection & Affordable Care Act (ACA) implements broad, historic changes to U.S. health care Expanded access to health insurance and care.
THE AIDS INSTITUTE The AIDS Institute HEALTH REFORM AND ADAP Emily McCloskey, Public Policy Associate Carl Schmid, Deputy Executive Director AIDS Drug.

THE AIDS INSTITUTE The AIDS Institute HEALTH REFORM AND ADAP Emily McCloskey, Public Policy Associate Carl Schmid, Deputy Executive Director AIDS Drug.
Medicare 101 Christian Reformed Church. June, 2012 2 Medicare 101 Introduction to Medicare Original Medicare Plan Medicare Supplement Insurance (Medigap)

Medicare 101 Christian Reformed Church. June, Medicare 101 Introduction to Medicare Original Medicare Plan Medicare Supplement Insurance (Medigap)
Return to KaiserEDU Tutorials

Return to KaiserEDU Tutorials
Strategic Implications of the New Medicare Prescription Drug Legislation G. Lawrence Atkins, PhD Schering-Plough Corporation The Pharma, Biotech and Device.

Strategic Implications of the New Medicare Prescription Drug Legislation G. Lawrence Atkins, PhD Schering-Plough Corporation The Pharma, Biotech and Device.
Medicare Modernization Act, Part D Prescription Drug Benefit Presentation for County Program Administrators September 1, 2005.

Medicare Modernization Act, Part D Prescription Drug Benefit Presentation for County Program Administrators September 1, 2005.
Health Reform: What It Means to Our Community. Health Reform: Key Provisions o Provides coverage to 32 million uninsured people by 2019. o Changes insurance.

Health Reform: What It Means to Our Community. Health Reform: Key Provisions o Provides coverage to 32 million uninsured people by o Changes insurance.
State Strategies: Expanding Prescription Drug Access Dee Mahan Families USA November 1, 2002.

State Strategies: Expanding Prescription Drug Access Dee Mahan Families USA November 1, 2002.
1 Elements Transforming the Delivery System Accountable Health Networks Receive payment for value not volume Drive quality and efficiency by providing.

1 Elements Transforming the Delivery System Accountable Health Networks Receive payment for value not volume Drive quality and efficiency by providing.
1 Variation in Medicare Part D Prescription Drug Plan Benefits, 2006 Leslie M. Greenwald, Ph.D. Principal Scientist RTI, International.

1 Variation in Medicare Part D Prescription Drug Plan Benefits, 2006 Leslie M. Greenwald, Ph.D. Principal Scientist RTI, International.
1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute National Academy of Social Insurance.

1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute National Academy of Social Insurance.

Similar presentations

Ads by Google